Sort by
Refine Your Search
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical technology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical techn ology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical techn ology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
people with subclinical and clinical disordered eating and related body image concerns and body image management efforts. Appointment at Grade 7 is dependent upon having been awarded a PhD; if this is not
-
of the post will involve synthesis and manufacture of prototype viral vectors, as well as testing their ability to treat experimental disease models, in vivo and in vitro. Other The advert will close on 05
-
adjustments or a more accessible format to apply for this job online or have any queries about the application process, please contact . The UCL Ways of Working supports colleagues to be successful and happy
-
the application process, please contact Biosciences staffing at . About you You must have a PhD (or be studying towards it) in Medical Physics or Bioengineering, Computational Neuroscience, Applied
-
,USA and Europe nationals. You will be part of a world-leading team in correlative in situ imaging of advanced manufacturing processes, with strong links to synchrotron facilities and industrial
-
hospital intensive care unit. The post holder will have primary responsibility for the development and evaluation of the system, and of the data processing and image display software. The post holder will
-
, and there will be the opportunity to apply for a PhD at UCL and undertake relevant research training. You will be based within the NHS Highly Specialised Service (HSS) for Rare Mitochondrial Disorders